Lotte Chilsung Beverage (005300) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Q3 consolidated sales were KRW 1,050.104bn, down 2.7% YoY; operating profit fell 37.9% to KRW 56.994bn and net profit fell 34.6% to KRW 40.544bn.
9M sales rose 1.3% YoY to KRW 3,115.531bn, while operating profit declined 10.4% to KRW 160.640bn and net profit fell 1.1% to KRW 94.064bn.
Financial highlights
Q3 consolidated gross profit was KRW 356.0bn, down 7.5% YoY; gross margin contracted to 33.9% from 35.7%.
Q3 profit before tax fell 34.7% YoY to KRW 52.2bn; net profit margin was 3.9% versus 5.7%.
9M gross profit was ₩1,054,800m and SG&A ₩892,690m, versus ₩1,048,452m and ₩868,425m in the prior-year period; 9M profit before tax was ₩123,534m versus ₩127,688m.
9M parent-attributable net income was ₩90,088m; Q3 basic EPS was ₩3,988 and 9M basic EPS ₩8,960.
Outlook and guidance
FY2026 consolidated sales forecast is KRW 4,080bn, up 2.7%; operating profit KRW 185bn, up 10.7%, with OPM of 4.5%, up 0.3 percentage points.
Q4 sales are forecast to rise 7.8% YoY to KRW 964.5bn; operating profit is expected to return to profitability at KRW 24.4bn from a KRW 12.0bn loss.
FY2026 segment forecasts: Beverage sales KRW 1,820bn and OP KRW 80bn; Liquor KRW 780bn and KRW 41bn; overseas subsidiaries KRW 1,626.1bn and KRW 63.1bn.
Product development priorities include zero-sugar and zero-calorie drinks, functional and protein beverages, and diversified low-alcohol and RTD offerings.
Overseas growth plans emphasize channel and market expansion, including Milkis and Let's Be beverage exports and liquor exports led by soju.
Latest events from Lotte Chilsung Beverage
- FY23 sales grew, but lower operating profit drives FY24 profitability initiatives.005300
Q4 2023 - Sales and net profit rose year-over-year, with strong beverage and liquor performance.005300
Q2 2026 - Q1 2026 delivered sharp profit gains, margin expansion, and robust overseas segment growth.005300
Q1 2026 - Domestic sales and profits fell in Q4 2025, but overseas growth and 2026 recovery are forecast.005300
Q4 2025 - Profits and margins rose in Q3 2025, with overseas and health-focused products driving growth.005300
Q3 2025 - Profit growth in Q2 2025 driven by overseas and zero-calorie products, with strong full-year outlook.005300
Q2 2025 - Sales and profits fell, but zero-calorie and health products drove segment growth.005300
Q3 2024 - Q2 sales up 38.1% YoY, but net profit and margins fell as overseas drove growth.005300
Q2 2024 - Q1 2025 revenue and profit declined, with rising debt ratio and segment performance shifts.005300
Q1 2025